Skip to search formSkip to main contentSkip to account menu

MVAC Regimen

Known as: Methotrexate-Vinblastine-Adriamycin-Cisplatin Regimen 
A regimen consisting of methotrexate, vinblastine, doxorubicin and cisplatin used for the treatment of advanced-stage bladder cancer.
National Institutes of Health

Related topics

Related topics

6 relations
Carcinoma of bladderCisplatinDoxorubicinM-VAC protocol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Systemtherapie des metastasierten Tumors des oberen Harntraktes
ZusammenfassungHintergrundMehr als 95 % der Tumoren des oberen Harntraktes (OHT) sind korrespondierend zum Harnblasenkarzinom… 
2015
2015
Exceptional Response to Pazopanib in a Patient with Urothelial Carcinoma Harboring FGFR3 Activating Mutation and Amplification.
2015
2015
A plea for uniform terminology for patients with urothelial carcinoma treated with chemotherapy prior to radical cystectomy: induction versus neoadjuvant chemotherapy.
2007
2007
Chemotherapy for advanced transitional cell carcinoma of the urothelium: cisplatin or carboplatin?
Highly Cited
2006
Highly Cited
2006
Complete long‐term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer
To report the long‐term follow‐up of patients with locally advanced bladder cancer treated with either adjuvant combined… 
Highly Cited
2005
Highly Cited
2005
The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy.
BACKGROUND The majority of patients with advanced urothelial cancer are elderly, but data regarding this specific age group are… 
Review
2003
Review
2003
Gallium nitrate in the treatment of bladder cancer.
Review
2000
Review
2000
Gemcitabine and cisplatin in locally advanced and/or metastatic bladder cancer.
Review
2000
Review
2000
Progress in the management of metastatic bladder cancer.
BACKGROUND Inadequate survival results from single agents in the management of advanced bladder cancer have prompted several… 
Review
1995
Review
1995
Management of bladder cancer.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)